Prolactin suppression enhances the effects of perioperative donor- specific blood transfusions on graft survival

Journal of Surgical Research

Volumn 64, Issue 2, 1996, Pages 190-197

  Martinelli, Giorgio P ^a   Liu, Hui ^a   Clarke, William P ^b   Heisenleder, Daniel J ^c   Knight, Richard J ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b Mays Cancer Center at UT Health San Antonio   (United States)

^c UNIVERSITY OF VIRGINIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BROMOCRIPTINE MESILATE; CONCANAVALIN A; CYCLOSPORIN; CYTOTOXIC ANTIBODY; DOMPERIDONE; LYMPHOCYTE ANTIBODY; MONOCLONAL ANTIBODY R73; PROLACTIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD TRANSFUSION; CELL PROLIFERATION; CONTROLLED STUDY; DOSE RESPONSE; GRAFT SURVIVAL; HEART TRANSPLANTATION; INTRAMUSCULAR DRUG ADMINISTRATION; LYMPH NODE CELL; MALE; MITOGENICITY; NONHUMAN; OSMOTIC PUMP; PERIOPERATIVE PERIOD; PRIORITY JOURNAL; PROLACTIN RELEASE; RAT; SPLEEN CELL; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0030221039     PISSN: 00224804     EISSN: None     Source Type: Journal    
DOI: 10.1006/jsre.1996.0327     Document Type: Article

References (44)

1. 1. Colson, Y. L., Zadach, K., Nalesnik, M., and Ildstad, S. T. Mixed allogeneic chimerism in the rat. Transplantation 60: 971, 1995.
2. 2. Homan, W. P., Williams, K. A., Millard, P. R., and Morris, P. J. Prolongation of renal allografts survival in the rat by pretreatment with donor antigen and cyclosporin A. Transplantation 31: 423, 1981.
3. 3. Miller, C. M., Martinelli, G. P., Racelis, D., and Schanzer, H. Prolongation of rat cardiac allografts by pretransplant administration of blood transfusions and cyclosporine A. Transplantation 33: 335, 1982.
4. 4. Yasumura, T., and Kahan, B. D. Prolongation of rat kidney allografts by pretransplant administration of donor antigen extract or whole blood transfusion combined with a short course of cyclosporine. Transplantation 36: 603, 1983.
5. 5. Okazaki, H., Maki, T., Wood, M., and Monaco, A. P. Effect of a single blood transfusion of donor-specific blood on skin allograft survival in mice. Transplantation 30: 421, 1981.
6. 6. Thomas, J., Carver, M., Cunningham, P., Park, K., Gonder, J., and Thomas, F. Promotion of incompatible allograft acceptance in rhesus monkeys given postransplant antilymphocyte globulin and donor bone marrow. In vivo parameters and immunohistologic evidence suggesting microchimerism. Transplantation 43: 332, 1987.
7. 7. Alexander, J. W., Babcock, G. F., First, M. R., Davies, C. B., Madden, R. L., Munda, R., Penn, I., Fidler, J. P., Coffer, B. R., Stephens, G., Schroeder, T. J., Hariharan, S., Cardi, M., Manzler, A., Cohen, L., Mendoza, N., Clyne, D., and Giese, F. The induction of immunologic hyporesponsiveness by preoperative donor-specific transfusions and cyclosporine in human cadaveric transplants. Transplantation 53: 423, 1992.
8. 8. Anderson, C. B., and Brennan, D. C. A sanguine outlook: The role of donor-specific blood transfusion in renal transplantation and tolerance. Transplant. Rev. 9: 49, 1995.
9. 9. Blalock, E. J. The syntax of immune-neuroendocrine communication. Immunol. Today 15: 504, 1994.
10. 10. Berczi, I., Nagy, E., De Toledo, S. M., Matusik, R. J., and Friesen, H. G. Pituitary hormones regulate c-myc and DNA synthesis in lymphoid tissue. J. Immunol. 146: 2201, 1991.
11. 11. Nagy, E., and Berczi, I. Hypophysectomized rats depend on residual prolactin for survival. Endocrinology 128: 2776, 1991.
12. 12. Ono, K., and Lindsey, E. S. Improved technique of heart transplantation in rats. J. Thorac. Cardiovasc. Surg. 517: 225, 1969.
13. 13. Hünig, T., Wallny, H.-J., Hartley, J. K., Alexandra, L., and Tiefenthaler, G. A monoclonal antibody to a constant determinant of the rat T cell antigen receptor that induces T cell activation. J. Exp. Med. 169: 73, 1989.
14. 3H thymidine. J. Immunol. Methods 67: 53, 1984.
15. 15. Knight, R. J., Polokoff, E. G., and Martinelli, G. P. Rapamycin, cyclosporine and perioperative donor-specific transfusions induce prolongation of cardiac allograft survival in the rat. Transplantation 58: 1014, 1994.
16. 16. Bernton, E., Bryant, H., Holaday, J., and Dave, J. Prolactin and prolactin secretagogues reverse immunosuppression in mice treated with cysteamine, glucocorticoids, or cyclosporin-A. Brain Behav. Immun. 6: 394, 1992.
17. 17. Chrousos, G. P. The hypothalamic-pituitary-adrenal axis and immune-mediated inflammation. N. Engl. J. Med. 332: 1351, 1995.
18. 18. Carrier, M., Wild, J., Pellettier, C., and JG, C. Bromocriptine as an adjuvant to cyclosporine immunosuppression after heart transplantation. Ann. Thorac. Surg. 49: 129, 1990.
19. 19. Wilner, M. L., Ettenger, R. B., Koyle, M. A., and Rosenthal, T. J. The effect of hyprolactinemia alone and in combination with cyclosporine on allograft rejection. Transplantation 49: 264, 1990.
20. 20. Clevenger, C. V., Russell, D. H., Appasamy, P. M., and Prystowsky, M. B. Regulation of interleukin 2-driven T-lymphocyte proliferation by prolactin. Proc. Natl. Acad. Sci. USA 87: 6460, 1990.
21. 21. Clevenger, C. V., Sillman, A. L., Hanley-Hyde, J., and Prystowsky, M. B. Requirement for prolactin during cell cycle regulated gene expression in cloned T-lymphocytes. Endocrinology 130: 3216, 1992.
22. 22. Mukherjee, P., Mastro, A. M., and C., H. W. Prolactin induction of interleukin-2 receptors on rat splenic lymphocytes. Endocrinology 126: 88, 1990.
23. 23. Gagnerault, M. C., Touraine, P., Savino, W., Kelly, P. A., and Dardenne, M. Expression of prolactin receptors in murine lymphoyd cells in normal and autoimmune situations. J. Immunol. 150: 5673, 1993.
24. 24. Bazan, J. F. Structural design and molecular evolution of a cytokine receptor superfamily. Proc. Natl. Acad. Sci. USA 87: 6934, 1990.
25. 25. Shen, G. K., Montgomery, D. W., Ulrich, E. D., Mahoney, K. R., and Zukoski, C. F. Up-regulation of prolactin gene expression and feedback modulation of lymphocyte proliferation during acute allograft rejection. Surgery 112: 387, 1992.
26. 26. Martinelli, G. P., Chung-Loy, R., Racelis, R., Miller, C. M., and Schanzer, H. Long-term prolongation of cardiac allografts by subtherapeutic levels of cyclosporine A in rats conditioned with pre-transplant blood transfusions and cyclosporine. Transplantation 39: 1, 1985.
27. 27. Cincotta, A. H., Knisely, T. L., Landry, R. J., Miers, W. R., Gutierrez, P. J. A., Esperanza, P., and Meier, A. H. The immunoregulatory effects of prolactin in mice are time of day dependent. Endocrinology 136: 2163, 1995.
28. 28. Hiestand, P. C., Gale, J. M., and Mekler, P. Soft immunosuppression by inhibition of prolactin release: Synergism with cyclosporine in kidney allograft survival and in the localized graft versus host reaction. Transplant. Proc. 18: 870, 1986.
29. 29. Eynon, E. E., and Parker, D. C. Do small B cells induce tolerance? Transplant. Proc. 23: 729, 1991.
30. 30. Wood, K. J. The induction of tolerance to alloantigens using MHC class I molecules. Curr. Opin. Immunol. 5: 759, 1993.
31. 31. Hiestand, P. C., Mekler, P., Nordmann, R., Grieder, A., and Permmongkol, C. Prolactin as a modulator of lymphocyte responsiveness provides a possible mechanism of action for cyclosporine. Proc. Natl. Acad. Sci. USA 83: 2599, 1986.
32. 32. Montgomery, D. W., Zukoski, C. T., Shah, G. N., Buckley, A. R., Pacholczyck, T., and Russell, D. H. Concanavalin-A stimulated murine splenocytes produce a factor with prolactin like bioactivity and immunoreactivity. Biochem. Biophys. Res. Commun. 145: 692, 1987.
33. 33. Pellegrini, I., Lebrun, J.-J., Ali, S., and Kelly, P. A. Expression of prolactin and its receptor on human lymphoid cells. Mol. Endocrinol 6: 1023, 1992.
34. 34. Sabharwal, P., Glaser, R., Lafuse, W., Varma, S., Liu, Q., Arkins, S., Kooijman, R., Kutz, L., Kelley, K. W., and Malarkey, W. B. Prolactin synthesized and secreted by human peripheral blood mononuclear cells: An autocrine growth factor for lymphoproliferation. Proc. Natl. Acad. Sci. USA 89: 7713, 1992.
35. 35. Di Carlo, R., Bole-Feysot, C., Gualillo, O., Meli, R., Nagano, M., and Kelly, P. A. Regulation of prolactin receptor mRNA expression in peripheral lymphocytes in rats in response to changes in serum concentration of prolactin. Endocrinology 136: 4713, 1995.
36. 36. Manni, A., Chambers, M. J., and Pearson, O. M. Prolactin induces its own receptors in rat liver. Endocrinology 103: 2168, 1978.
37. 37. Bernton, E. W., Meltzer, M. S., and Holaday, J. W. Suppression of macrophage activation and T lymphocyte function in hypopolactinemic mice. Science 239: 401, 1988.
38. 38. Chen, Y., and Johnson, A. G. In vivo activation of macrophages by prolactin from young and aging mice. Int. J. Immunopharmacol. 15: 39, 1992.
39. 39. Munck, A., Guyre, P. M., and Holbrook, N. J. Physiological function of glucocorticoids in stress and their relation to pharmacological actions. Endocr. Rev. 5: 425, 1994.
40. 40. Sandi, C., Cambronero, J. C., Borrell, J., and Guaza, C. Mutually antagonistic effects of corticosterone and prolactin on rat lymphocyte proliferation. Neuroendocrinology 56: 574, 1992.
41. 41. Daynes, R. A., Meikle, A. W., and Araneo, B. A. Locally active steroid hormones may facilitate compartmentalization of immunity by regulating the types of lymphokines produced by helper T cells. Res. Immunol. 142: 40, 1990.
42. 42. Rook, G. A. W., Hernandez-Pando, R., and Lightman, S. L. Hormones, peripherally activated prohormones and regulation of the Th1/Th2 balance. Immunol. Today 15: 301, 1994.
43. 43. Street, N. E., and Mosman, T. R. Functional diversity of T lymphocytes due to secretion of different cytokine patterns. FASEB J. 5: 171, 1991.
44. 44. Nickerson, P. W., Steurer, W., Steiger, J., Zheng, X., Steele, A. W., and Strom, T. B. Cytokines and the Th1/Th2 paradigm in transplantation. Curr. Opin. Immunol. 6: 757, 1994.